WallStreetZen

NYSE: JNJ
Johnson & Johnson Earnings & Revenue

JNJ past earnings growth

How has JNJ's earnings growth performed historically?
Company
-2.27%
Industry
13.35%
Market
37.62%
JNJ's earnings have grown slower (0.11% per year) than the US Drug Manufacturers - General industry average (4.06%)
Performance
JNJ's earnings have grown slower (0.11% per year) than the US market average (19.73%)
Performance
JNJ's earnings growth is slowing down - its growth over the last year (-2.27%) is below its 5-year compound annual rate (0.11%)
Performance

JNJ past revenue growth

How has JNJ's revenue growth performed historically?
Company
0.64%
Industry
12.11%
Market
20.3%
JNJ's revenue has grown slower (3.34% per year) than the US Drug Manufacturers - General industry average (5.94%)
Performance
JNJ's revenue has grown slower (3.34% per year) than the US market average (18.37%)
Performance
JNJ's revenue growth is slowing down - its growth over the last year (0.64%) is below its 5-year compound annual rate (3.34%)
Performance

JNJ earnings and revenue history

Current Revenue
$82.6B
Current Earnings
$14.7B
Current Profit Margin
17.8%
JNJ's has not demonstrated consistent long-term earnings growth over the past 10 years (15.26%)
Performance

JNJ Return on equity

Current Company
23.4%
Current Industry
35.6%
Current Market
49.8%
JNJ's Return on Equity (23.4%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

JNJ Return on assets

Current Company
8.9%
Current Industry
6.9%
Current Market
5.4%
JNJ is generating higher Return on Assets (8.9%) than the US Drug Manufacturers - General industry average (7.12%)
Performance

JNJ Return on capital employed

Current Company
12.61%
Current Industry
11.1%
JNJ's ability to generate Return on Capital (12.61%) has decreased compared to 3 years ago (14.68%)
Performance

JNJ earnings dates

Next earnings date
Apr 20, 2021

Johnson & Johnson Earnings & Revenue FAQ

What were JNJ's earnings last quarter?

On Jan 26, 2021, Johnson & Johnson (NYSE: JNJ) reported Q4 2020 earnings per share (EPS) of $0.66, up 56.86% year over year. Total Johnson & Johnson earnings for the quarter were $1.74 billion. In the same quarter last year, Johnson & Johnson's earnings per share (EPS) was $1.53.

What was JNJ's earnings growth in the past year?

As of Q2 2021, Johnson & Johnson's earnings has grown -2.27% year over year. This is 15.63 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 13.35%. Johnson & Johnson's earnings in the past year totalled $14.71 billion.

What is JNJ's earnings date?

Johnson & Johnson's earnings date is Apr 20, 2021. Add JNJ to your watchlist to be reminded of JNJ's next earnings announcement.

What was JNJ's revenue last quarter?

On Jan 26, 2021, Johnson & Johnson (NYSE: JNJ) reported Q4 2020 revenue of $22.48 billion up 8.33% year over year. In the same quarter last year, Johnson & Johnson's revenue was $20.75 billion.

What was JNJ's revenue growth in the past year?

As of Q2 2021, Johnson & Johnson's revenue has grown 0.64% year over year. This is 11.47 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.11%. Johnson & Johnson's revenue in the past year totalled $82.58 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.